Skip to content
Open access · CC-BY via OpenAlex

Watching the clock in glioblastoma

Priscilla Chan, Jeremy N. Rich, Steve A. Kay

Neuro-Oncology · 2023 · ▲ 41 citations

Abstract

Glioblastoma (GBM) is the most prevalent malignant primary brain tumor, accounting for 14.2% of all diagnosed tumors and 50.1% of all malignant tumors, and the median survival time is approximately 8 months irrespective of whether a patient receives treatment without significant improvement despite expansive research (Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neurooncology. 2022; 24(suppl 5):v1-v95.). Recently, important roles for the circadian clock in GBM tumorigenesis have been reported. Positive regulators of circadian-controlled transcription, brain and muscle ARNT-like 1 (BMAL1), and circadian locomotor output cycles kaput (CLOCK), are highly expressed also in GBM and correlated with poor patient prognosis. BMAL1 and CLOCK promote the maintenance of GBM stem cells (GSCs) and the establishment of a pro-tumorigenic tumor microenvironment (TME), suggesting that targeting the core clock proteins may augment GBM treatment. Here, we review findings that highlight the critical role the circadian clock plays in GBM biology and the strategies by which the circadian clock can be leveraged for GBM treatment in the clinic moving forward.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/neuonc/noad107
Canonical
link ↗
Fetched
2026-07-25 MST

Cite this

APA
Chan, P., Rich, J.N., &amp; Kay, S.A. (2023). Watching the clock in glioblastoma. <em>Neuro-Oncology</em>. https://doi.org/10.1093/neuonc/noad107
Vancouver
Chan P, Rich JN, Kay SA. Watching the clock in glioblastoma. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad107.
BibTeX
@article{priscilla2023Watchi, title = {Watching the clock in glioblastoma}, author = {Priscilla Chan and Jeremy N. Rich and Steve A. Kay}, journal = {Neuro-Oncology}, year = {2023}, doi = {10.1093/neuonc/noad107}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings